These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34471382)

  • 1. Prognostic Value of an m
    Li H; Jiang H; Huang Z; Chen Z; Chen N
    Cancer Manag Res; 2021; 13():6673-6687. PubMed ID: 34471382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of m
    Wu J; Hou C; Wang Y; Wang Z; Li P; Wang Z
    Int J Genomics; 2021; 2021():3803724. PubMed ID: 34631874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a Methylation-Regulating Genes Prognostic Signature to Predict the Prognosis and Aid Immunotherapy of Clear Cell Renal Cell Carcinoma.
    Zhang L; Su Z; Hong F; Wang L
    Front Cell Dev Biol; 2022; 10():832803. PubMed ID: 35309925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of m
    Wang J; Zhang C; He W; Gou X
    Front Oncol; 2020; 10():3. PubMed ID: 32038982
    [No Abstract]   [Full Text] [Related]  

  • 5. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
    Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X
    Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a m
    Chen J; Yu K; Zhong G; Shen W
    Cancer Cell Int; 2020; 20():157. PubMed ID: 32419773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinoma.
    Wang Z; Zhang M; Seery S; Zheng G; Wang W; Zhao Y; Wang X; Zhang Y
    Oncol Lett; 2022 Aug; 24(2):250. PubMed ID: 35761938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a New Prognostic Risk Signature of Clear Cell Renal Cell Carcinoma Based on N
    Zhang Y; Yao Y; Qi X; Li J; Liu M; Che X; Xu Y; Wu G
    J Immunol Res; 2021; 2021():6617841. PubMed ID: 33628845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation regulator-based signature for predicting clear cell renal cell carcinoma prognosis.
    Gong W; Yang R; Wang Z
    Am J Transl Res; 2023; 15(4):2443-2459. PubMed ID: 37193150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular subtypes of m
    Guan B; Ren F; Shan W; Zhang S
    Transl Cancer Res; 2022 Mar; 11(3):508-518. PubMed ID: 35402182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis.
    Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y
    Front Genet; 2022; 13():816173. PubMed ID: 35281843
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic Characteristics and Immune Effects of N
    Li L; Tao Z; Zhao Y; Li M; Zheng J; Li Z; Chen X
    Front Genet; 2022; 13():864383. PubMed ID: 35571068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a m
    Zhao X; Cui L
    Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer.
    Xu LC; Pan JX; Pan HD
    Cancer Manag Res; 2020; 12():5385-5394. PubMed ID: 32753956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel m
    Chen S; Zhang N; Zhang E; Wang T; Jiang L; Wang X; Zheng J
    Front Cell Dev Biol; 2020; 8():616972. PubMed ID: 33553151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma.
    Chen X; Tu J; Ma L; Huang Y; Yang C; Yuan X
    Int J Gen Med; 2022; 15():3215-3235. PubMed ID: 35342303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis.
    Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L
    Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
    Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
    Front Oncol; 2020; 10():1119. PubMed ID: 32974125
    [No Abstract]   [Full Text] [Related]  

  • 20. A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma.
    Jiang W; Guo Q; Wang C; Zhu Y
    Cancer Cell Int; 2019; 19():208. PubMed ID: 31404170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.